In what has been a watershed year for diabetes treatment, Eli Lilly and Boehringer Ingelheim declared another victory Wednesday – this one for children and adolescents with Type 2 Diabetes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,